Prevalence of alcohol and drug abuse in schizophrenic inpatients.
about
Q24197685Management of "dual diagnosis" patients : consensus, controversies and considerationsCannabis abuse and brain morphology in schizophrenia: a review of the available evidence.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.Concurrent substance-related disorders and mental illness: the North American experience.New pharmacological approaches for the treatment of alcoholism.Comorbid substance abuse and brain morphology in recent-onset psychosisSuicide risk in schizophrenia: learning from the past to change the future.The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use.Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders.Illicit drug use in heavy smokers with and without schizophrenia.Substance use disorder and schizophrenia: prevalence and sociodemographic characteristics in the Latin American population.Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision.The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disordersA comparative study of two methods for attaining constant alcohol levelsPrevalence of Substance Use in Patients Diagnosed with Schizophrenia.Comprehensive Psychopathological Assessment Based on the Association for Methodology and Documentation in Psychiatry (AMDP) System: Development, Methodological Foundation, Application in Clinical Routine, and Research.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactatioPharmacological treatment of schizophrenia with comorbid substance use disorder.Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia.Medical disorders in the schizophrenic patient.How is substance use linked to psychosis? A study of the course and patterns of substance dependence in psychosis.Substance use disorders among psychotic patients admitted to inpatient psychiatric care.A comparative study on schizophrenic patients with dual diagnosis.Characteristics of immigrant and non-immigrant patients in a dual-diagnosis psychiatric ward and treatment implications.Comparison of four groups of substance-abusing in-patients with different psychiatric comorbidity.The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC).Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial.An evaluation of type A and B alcoholics.Paranoia and maladaptive behaviours in homelessness: The mediating role of emotion regulation.Characteristics of alleged homicide offenders with and without schizophrenia in Sichuan, China.Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.Factors associated with relapse in patients with schizophrenia
P2860
Q24197685-AA39FD9E-2EC4-4866-8810-9DA92047C985Q30400782-39617F72-C472-4906-95ED-60C7C3E9DD42Q30558464-754E66AD-D53B-46E9-B981-A96BF4EE9FEDQ33223628-0C1A3072-53F7-4F8F-B18C-1C446016A489Q34482028-8C9E2EB6-4A06-421C-AF52-635AB48F8DE9Q34582243-46E1C5DA-10FE-4177-9E0F-39CA67BBD519Q34901749-85F1DCE4-2AC3-4777-8C57-C466FB9F6CBDQ35738863-DAE7D683-D2E4-42EA-A52D-CACB51C720D7Q36059843-9FABDD54-4C29-446D-9D89-6485D3319CA0Q36083997-C297F965-C007-4FE3-A184-46B2685E6F87Q36087073-923BAC8D-2701-4656-91A7-89A832609726Q36092716-22A25909-3DF7-446D-84C6-7BD602805436Q36231851-6C4B2654-3255-4894-9DC7-9C39F84489E4Q36570221-81AC002C-C777-47DA-AFC1-F7DC04B23269Q37142448-39F99BEF-4F44-4AB1-9D1E-F16005725362Q37704084-0C3491C7-AF00-4032-B648-772A392F16E1Q37740645-34FB51E4-CD81-4141-A9D2-1FD32BEACBA8Q38395937-A454726C-ADF0-4FAD-AEA8-C37BE3352594Q38658672-AB4EE493-5888-4472-951C-C63AB31DDD95Q39340879-FBD408C9-C77C-4DAA-B252-93EB6E1C235CQ40433554-E0547C37-0006-40DE-BDFB-B83DEB49FE3AQ43100062-83A5BB87-A8E4-4BC5-A079-143029D997D7Q43471662-0268AA20-E0DF-48C5-8A21-C87FCA947021Q43836245-ADECC56B-E15D-4695-B12C-360983379357Q45182555-B5CCEC4B-FBA7-414E-A6EE-D11E234A7D38Q45234123-C702F4A8-2DFE-44AA-815E-63788EC7D165Q45778447-2C1E8D11-21C3-42A3-BA6F-DEBADB2ADFB4Q46491009-4A578442-56B7-430C-A221-871277BA9449Q46549205-35E0B111-57CE-4F6A-9BA5-74E84308E34DQ47278050-4AD1ADE7-6631-452F-A9E5-82CCECE0BB95Q47593250-C86FCDFA-7500-4921-94F5-8B88C8B3A87DQ52016145-711DDF22-CE11-4FEA-8BDF-CCF3C7FA5285Q57602650-3E8CEFFC-7743-4C90-B8B9-9FC2F4F61B7E
P2860
Prevalence of alcohol and drug abuse in schizophrenic inpatients.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Prevalence of alcohol and drug abuse in schizophrenic inpatients.
@en
type
label
Prevalence of alcohol and drug abuse in schizophrenic inpatients.
@en
prefLabel
Prevalence of alcohol and drug abuse in schizophrenic inpatients.
@en
P2093
P2860
P356
P1476
Prevalence of alcohol and drug abuse in schizophrenic inpatients.
@en
P2093
N Kathmann
R Holzbach
S Hofstetter
P2860
P2888
P304
P356
10.1007/BF02190250
P577
1993-01-01T00:00:00Z